Thermo Fisher Scientific Inc Shows Mixed Performance in Analysis

Mixed results for Thermo Fisher Scientific Inc. A recent report highlights both strengths and weaknesses in its growth strategy, with a 69% rating overall, yet flagged issues with earnings persistence and debt levels.

Date: 07-02-2025

AI Rating: 5

Thermo Fisher Scientific Inc (TMO) has been analyzed using the Growth Investor strategy, which seeks growth stocks with consistent accelerating earnings and sales growth, reasonable valuations, and low debt. The company achieved a 69% rating based on its fundamentals and valuation, indicating some interest from the strategy, although it falls short of the 80% threshold that generally signals more robust interest.

Several key performance areas were examined:

P/E Ratio: PASS
Revenue Growth in relation to EPS Growth: PASS
Sales Growth Rate: PASS
Current Quarter Earnings: PASS
Quarterly Earnings One Year Ago: PASS
Positive Earnings Growth Rate for Current Quarter: PASS
EPS Growth for Current Quarter Must be Greater than Prior 3 Quarters: PASS
EPS Growth for Current Quarter Must be Greater than Historical Growth Rate: PASS
Earnings Growth Rate for the Past Several Quarters: FAIL
Earnings Persistence: FAIL
Long-term EPS Growth: FAIL
Total Debt/Equity Ratio: FAIL
Insider Transactions: PASS

The analysis indicates some strong points, especially in P/E ratio, revenue, sales growth, and current earnings. However, serious concerns arise from the failures in earnings growth rate and earnings persistence, which could negatively impact investor confidence. Additionally, the debt levels pose a risk that cannot be overlooked. This mixed performance may lead to cautious sentiment among investors moving forward.

Stocks: TMO